Expansion of HIV screening worthwhile

NewsGuard 100/100 Score

According to researchers, screening for the AIDS virus to include every American at least once and the highest-risk people once a year could prevent more than 80,000 infections over the next 20 years. The team from Yale University in Connecticut and Stanford University in California reported that if treatment for infected people were integrated into such a program, it would prevent an estimated 212,000 new infections.

At present the U.S. Centers for Disease Control and Prevention recommends universal screening, testing everyone at least once for the human immunodeficiency virus that causes AIDS. But little or no funding has gone to such a program. 600,000 Americans have died of AIDS, 1.1 million are infected and 21 percent of those infected do not know it because they have not been tested and more than 56,000 Americans get infected every year with HIV.

Researcher Elisa Long and colleagues at Stanford write, “Our model projects that approximately 1.23 million new HIV infections will occur over 20 years, with 74 percent occurring among high-risk persons.” The report is published in the Annals of Internal Medicine. High risk individuals are homo and bisexual men, blacks and injection drug users. They add, “One-time screening of low-risk persons combined with annual screening of high-risk persons prevents 81,991 infections (6.7 percent of the projected total).” However they say a strategy that includes screening everyone once in their lives and annual screening of the people at highest risk, plus treatment of 75 percent of those infected, would prevent more than 212,000 infections, or 17 percent of the total. The team also tried to find whether testing and treating nearly everyone could eliminate HIV in the United States. They write, “Such a strategy could prevent 24 percent of new infections but would not prevent more than 40,000 new infections each year.”

Stanford’s Dr. Owens said, “You do the most for health outcomes by scaling up these programs together. They are synergistic.” He adds that this type of program would cost $26.9 billion over 20 years, or about $22,000 per quality-adjusted life year saved, an accepted measure that reflects both how long people live and their quality of life. Long said, “We find that expanded screening and treatment could offer substantial health benefits, preventing 15 to 20 percent of new cases… And the strategy of one-time screening of low-risk individuals and annual screening of high-risk individuals is very cost-effective.”

Dr. Ananya Mandal

Written by

Dr. Ananya Mandal

Dr. Ananya Mandal is a doctor by profession, lecturer by vocation and a medical writer by passion. She specialized in Clinical Pharmacology after her bachelor's (MBBS). For her, health communication is not just writing complicated reviews for professionals but making medical knowledge understandable and available to the general public as well.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Mandal, Ananya. (2018, August 23). Expansion of HIV screening worthwhile. News-Medical. Retrieved on April 25, 2024 from https://www.news-medical.net/news/20101221/Expansion-of-HIV-screening-worthwhile.aspx.

  • MLA

    Mandal, Ananya. "Expansion of HIV screening worthwhile". News-Medical. 25 April 2024. <https://www.news-medical.net/news/20101221/Expansion-of-HIV-screening-worthwhile.aspx>.

  • Chicago

    Mandal, Ananya. "Expansion of HIV screening worthwhile". News-Medical. https://www.news-medical.net/news/20101221/Expansion-of-HIV-screening-worthwhile.aspx. (accessed April 25, 2024).

  • Harvard

    Mandal, Ananya. 2018. Expansion of HIV screening worthwhile. News-Medical, viewed 25 April 2024, https://www.news-medical.net/news/20101221/Expansion-of-HIV-screening-worthwhile.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Breakthrough study offers hope for an effective HIV cure